Evidence for a graft-versus-tumor effect in refractory ovarian cancer

Journal of Cancer Research and Clinical Oncology

Volumn 129, Issue 1, 2003, Pages 12-16

  Hanel M ^a   Bornhauser M ^a   Muller J ^a   Thiede, C ^a   Ehninger, G ^a   Kroschinsky, F ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Allogeneic and autologous stem cell transplantation; High dose therapy; Ovarian cancer; Salvage therapy

Indexed keywords

ANTINEOPLASTIC AGENT; BUSULFAN; CARBOPLATIN; CIDOFOVIR; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOTOXIC AGENT; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PACLITAXEL; PLATINUM; PREDNISOLONE; TOPOTECAN; TREOSULFAN;

ADULT; ALLOGRAFT; ARTICLE; AUTOGRAFT; AUTOTRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; CLINICAL FEATURE; DRUG MEGADOSE; FEMALE; GASTROINTESTINAL DISEASE; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MUCOSA INFLAMMATION; OVARY CANCER; PRIORITY JOURNAL; SALVAGE THERAPY; SIBLING; SKIN DISEASE;

EID: 0037246568     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-002-0399-1     Document Type: Article

References (23)

1. Bay JO, Fleury J, Choufi B, Tournilhac O, Vincent C, Bailly C, Dauplat J, Viens P, Faucher C, Blaise D (2002) Allogeneic hematopoietic stem cell transplantation in ovarian cancer: results of five patients. Bone Marrow Transplant 30:95-102
2. Bertucci F, Viens P, Delpero JR, Bardou VJ, Faucher C, Houvenaeghel G, Maraninchi D (2000) High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second-look laparotomy in patients with chemosensitive advanced ovarian cancer: long-term results. Bone Marrow Transplant 26:61-67
3. Bojko P, Scheulen ME, Hilger R, Oberhoff C, Schindler AE, Seeber S (2001) High-dose chemotherapy with peripheral blood stem cell transplantation for patients with advanced ovarian cancer. J Cancer Res Clin Oncol 127:243-250
4. Childs R, Chernoff A, Contentin N, Bahceci E, Shrump D, Leitman S, Read EJ, Tisdale J, Dunbar C, Linehan WM, Young NS, Barrett AJ (2000) Regression of metastatic renal-cell carcinoma after non-myeloablative allogeneic peripheral blood stem cell transplantation. N Engl J Med 343: 750-758
5. Eibl B, Schwaighofer H, Nachbaur D, Marth C, Gachter A, Knapp R, Bock G, Gassner C, Schiller L, Petersen F, Niederwieser D (1996) Evidence for a graft-versus-tumor effect in a patient treated with marrow ablative chemotherapy and allogeneic bone marrow transplantation for breast cancer. Blood 88:1501-1508
6. Gratwohl A, Passweg J, Baldomero H, Urbano-Ispizua A for the European Group of Blood and Marrow Transplantation (EBMT) (2001) Hematopoietic stem cell transplantation activity in Europe 1999. Bone Marrow Transplant 27:899-916
7. Hogberg T, Glimelius B, Nygren P for the SBU-group (2001) A systemic overview of chemotherapy effects in ovarian cancer. Acta Oncol 40:340-360
8. Holmberg LA, Demirer T, Rowley S, Buckner CD, Goodman G, Maziarz R, Klarnet J, Zuckerman N, Harrer G, McCloskey R, Gersh R, Goldberg R, Nichols W, Jacobs A, Weiden P, Montgomery P, Rivkin S, Appelbaum FR, Bensinger WI (1998) High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cells (PBSC) rescue in patients with advanced stage III/IV ovarian cancer. Bone Marrow Transplant 22:651-659
9. Jones RJ, Ambinder RF, Piantadosi S, Santos GW (1991) Evidence of graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation. Blood 77:649-653
10. Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W, Ljungman P, Ferrant A, Verdonck L, Niederwieser D (1995) Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood 86:2041-2050
11. Legros M, Dauplat H, Fleury J, Cure H, Suzanne F, Chassagne J, Bay JO, Sol C, Canis M, Condat P, Choufi B, Tavernier F, Glenat C, Chollet P, Plagne R (1997) High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: long-term results. J Clin Oncol 15:1302-1308
12. Morgan RJ, Doroshow JH, Leong L, Schriber J, Shibata S, Forman S, Hamasaki V, Margolin K, Somlo G, Alvarnas J, McNamara M, Longmate J, Raschko J, Chow W, Vasilev S, McGonigle K, Yen Y (2001) Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer. Bone Marrow Transplant 28:859-863
13. Peethambaram PP, Long HJ (2002) Second-line and subsequent therapy for ovarian carcinoma. Curr Oncol Rep 4:159-164
14. Platzbecker U, Bandt D, Thiede C, Helwig A, Freiberg-Richter J, Schuler U, Plettig R, Geissler G, Rethwilm A, Ehninger G, Bornhauser M (2001) Successful preemptive cidofovir for CMV antigenemia after dose-reduced conditioning and allogeneic blood stem cell transplantation. Transplantation 71:880-885
15. Rosti G, Ferrante P, Ledermann J, Levyraz S, Ladenstein R, Koscileniak E, Crown J, Dazzi C, Cariello A, Marangolo M (2002) High-dose chemotherapy for solid tumors: results of the EBMT. Crit Rev Oncol Hematol 41:129-140
16. Salerno MG, Ferrandina G, Greggi S, Pierelli L, Menichella G, Leone G, Scambia G, Manusco S (2001) High-dose chemotherapy as a consolidation approach in advanced ovarian cancer: long-term results. Bone Marrow Transplant 27:1017-1025
17. Shinozuka T, Muramatsu T, Miyamoto T, Hirasawa T, Murakami M, Makino T, Sadahiro S, Tanaka Y, Yasuda M (1999) Longterm results and prognostic analysis in advanced and recurrent/refractory epithelial ovarian cancer treated by high-dose cyclophosphamide, adriamycin, and cisplatin with autologous bone marrow transplantation. Int J Clin Oncol 4:273-279
18. Stiff PJ, Veum-Stone J, Lazarus HM, Ayash L, Edwards JR, Keating A, Klein JP, Oblon DJ, Shea TC, Thome S, Horowitz MM (2000) High-dose chemotherapy and autologous stem-cell transplantation for ovarian cancer: an Autologous Blood and Marrow Transplant Registry report. Ann Intern Med 133:504-515
19. Thiede C, Florek M, Bornhauser M, Ritter M, Mohr B, Brendel C, Ehninger G, Neubauer A (1999) Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection. Bone Marrow Transplant 23:1055-1060
20. Ueno NT, Rondon G, Mirza NQ, Geisler DK, Anderlini P, Giralt SA, Andersson BS, Claxton DF, Gajewski JL, Khouri IF, Korbling M, Mehra RC, Przepiorka D, Rahman Z, Samuels BI, van Besien K, Hortobagy GN, Champlin RE (1998) Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer. J Clin Oncol 16:986-993
21. Verdonck LF, Lokhorst HM, Dekker AW, Nieuwenhuis HK, Petersen EJ (1996) Graft-versus-myeloma effect in two cases. Lancet 347:800-801
22. Wandt H, Birkmann J, Denzel T, Schäfer K, Schwab G, Pilz D, Egger H, Both A, Gallmeier WM (1999) Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells: a phase I/II study in advanced ovarian cancer. Bone Marrow Transplant 23:763-770
23. Weiden PL, Flournoy N, Thomas ED, Prentice R, Fefer A, Buckner CD, Storb R (1979) Antileukemic effects of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med 300:1068-1073